SANGAMO THERAPEUTICS, INC. (SGMOQ) Net income 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$122.9MFY2025 · since FY2016: -$71.7M → -$122.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$122.9M | -25.5% |
| FY2024 | -$97.9M | +62.0% |
| FY2023 | -$257.8M | -34.1% |
| FY2022 | -$192.3M | -7.8% |
| FY2021 | -$178.3M | -47.3% |
| FY2020 | -$121.0M | -27.1% |
| FY2019 | -$95.2M | -39.3% |
| FY2018 | -$68.3M | -25.2% |
| FY2017 | -$54.6M | +23.8% |
| FY2016 | -$71.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice